ASTRAZENECA PLC (AZN)
Clinical trial NCT06137144 updates: 1. completion date: 2029-04-30 → 2029-05-03 2. primary completion date: 2029-04-30 → 2029-05-03
Clinical trial NCT06137144 updates: 1. completion date: 2029-04-30 → 2029-05-03 2. primary completion date: 2029-04-30 → 2029-05-03
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical